Optical instrument for the study of time recovery from total disability glare vision.


Journal

Applied optics
ISSN: 1539-4522
Titre abrégé: Appl Opt
Pays: United States
ID NLM: 0247660

Informations de publication

Date de publication:
20 Mar 2022
Historique:
entrez: 25 3 2022
pubmed: 26 3 2022
medline: 1 4 2022
Statut: ppublish

Résumé

Disability glare is defined as the loss of contrast sensitivity of the retinal image due to intraocular straylight originated from the presence of an intense and broad bright light in the field of vision. This loss of vision can range between vision loss at high spatial frequencies or total temporal blindness. If the extreme case occurs, the recovery time is crucial in night driving conditions or those professional activities in which maximum visual acuity is required at any moment. The recovery time depends mainly on the intensity and glare angle of the light source, ocular straylight, and the photoreceptor response at the retina. The recovery time can also be affected by ocular pathologies, aging, or physiological factors that increase ocular straylight. The aim of this work is to develop a new optical instrument based on psychophysical methodology as well as to investigate the recovery time from total disability glare (photobleaching) as a function of the contrast of the visual target and the glare angle of the source in healthy volunteers. Results showed significant exponential correlation between recovery time and contrast of the visual target and linear correlation between contrast sensitivity and the glare angle. Those findings allowed to obtain an empirical expression to compute the recovery time required to restore contrast sensitivity baseline vision after photobleaching. Finally, a statistical dependence of recovery time with age was found for short glare angles that disappear as the glare angle increases.

Identifiants

pubmed: 35333264
pii: 470517
doi: 10.1364/AO.453842
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

2438-2443

Auteurs

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH